Number of Shares
6.00 Mil
Current Holdings Value*
$164.11 Mil
% of Portfolio
1.84%
Total Estimate Gain
$109.49 Mil
% of Total Estimate Gain
54.89%

BAKER BROS. ADVISORS LP's Kymera Therapeutics Inc Holding Summary

As of 2025-03-31, BAKER BROS. ADVISORS LP held 6.00 Mil shares of Kymera Therapeutics Inc(KYMR), totaling $164.11 Mil. This investment constitutes 1.84% of their stock portfolio, and BAKER BROS. ADVISORS LP now holds 9.21% of the outstanding Kymera Therapeutics Inc(KYMR) stock.

The initial trade took place in 2020Q3. And since then BAKER BROS. ADVISORS LP has made 7 purchases of KYMR, at an average price of $29.92, for a total of 6.67 Mil shares. In addition, there have been 1 sales at an average price of $43.58 for 15,111.00 shares. Based on historical transaction data and KYMR's current price of $46.35, BAKER BROS. ADVISORS LP's estimated gain on his KYMR holdings is $109.49 Mil, reflecting a 54.89% gain to date.

BAKER BROS. ADVISORS LP KYMR ($46.35) Holding Chart

BAKER BROS. ADVISORS LP KYMR ($46.35) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1